In recent years, metallodrugs have emerged as captivating and promising compounds in the fields of cancer therapy and antimicrobial agents. While noble metals have shown remarkable biological activity, increasing interest lies in utilizing more abundant and cost-effective metals in medicinal chemistry. This is primarily due to their pivotal role in biological processes and their lower cost compared to precious metals. Among these, copper(II) complexes have emerged with promising applications in medicine. Notably, copper compounds bearing Schiff bases stand out as innovative metallodrugs. They exhibit intriguing cytotoxic properties against a wide range of cancer cell lines, while also demonstrating inhibitory effects on prevalent bacterial and fungal strains. Nevertheless, research into Cu(II) complexes with Schiff bases remains of paramount interest. One strategic avenue to bolster their biological activity involves the introduction of fluorine groups into the ligands. This approach has demonstrated a significant augmentation in efficacy and selectivity, particularly in targeting cancer cells and microbial pathogens, because fluorine incorporation can improve metabolic stability and cellular uptake. This further reinforces the therapeutic potential of these metallodrugs. Thanks to these promising outcomes, research into the development of Cu(II) complexes with fluorinated Schiff bases is advancing significantly. This holds immense potential for progressing the field of medicinal chemistry, with the aim of addressing unmet clinical needs in both cancer therapy and antimicrobial treatment. This review comprehensively explores the latest advancements in Cu(II) complexes bearing fluorinated Schiff bases, encompassing diverse coordination modes. It delves into their scope and applications in cytotoxic evaluations, as well as their efficacy as antimicrobial and antifungal agents.

The synergistic combination of vanadium and pincer ligands produces complexes with potential antidiabetic, antibacterial, antiviral, antiparasitic, and anticancer activities with enhanced stability, improved bioavailability, and greater specificity.

The electrochemical reduction of carbon dioxide (CO₂) to methane (CH₄) holds tremendous potential in mitigating greenhouse gas emissions and producing renewable fuels. Thus, this review provides a comprehensive overview of the utilization of copper-based metal–organic frameworks (Cu-MOFs) as catalysts for this transformative process. Diverse key aspects of Cu-MOFs that make them ideal candidates for CO₂ reduction are discussed, including their high surface areas, tunable pore sizes, and customizable active sites. Furthermore, recent advances in the design and synthesis of Cu-MOFs tailored specifically for enhanced catalytic activity and selectivity towards CH₄ production are highlighted. Additionally, mechanistic insights into the CO₂ reduction process on Cu-MOF catalysts are examined. Moreover, the recent application of diverse Cu-MOFs and derived materials in electrochemical reduction systems is discussed, and future research directions and potential applications of Cu-MOFs in sustainable energy conversion technologies are outlined. Thus, this review provides valuable insights into the current state of the art and the prospects for utilizing Cu-MOFs as efficient catalysts for the electrochemical conversion of CO₂ to CH₄, offering a pathway towards a greener and more sustainable energy future.

The synthesis and characterization of novel gold(I) complexes containing hydrophilic ferrocenylphosphino sulfonate ligands, i.e., compounds [AuCl{(η⁵-C₅H₃PR₂(SO₃ⁱPr))Fe(η⁵-C₅H₅)}] (R = Ph (2a), p-Tol (2b), Cy (2c)), are presented, including a single-crystal X-ray diffraction study on 2a. Complexes 2a–c were checked as catalysts for the intermolecular addition of carboxylic acids to nonactivated internal alkynes using water as a green reaction medium. The best results in terms of activity were obtained with 2a in combination with AgOAc, which was able to promote the selective anti addition of a variety of aromatic, aliphatic, and α,β-unsaturated carboxylic acids to both symmetrical and unsymmetrical internal alkynes at 60 °C, employing metal loadings of only 2 mol %.

A series of Pd( ii ) and Cu( ii ) complexes bearing N -aryl fluorinated O -glycoconjugate Schiff base ligands were synthesized and fully characterized, and their potential anticancer activities were explored.